Is Archit Organosys overvalued or undervalued?

As of 13 November 2025, Archit Organosys' valuation grade has moved from attractive to fair. The company appears to be overvalued based on its current metrics. Notable ratios include a PE ratio of 147.70, an EV to EBITDA of 18.19, and a PEG ratio of 0.01, which suggests a significant disparity in growth expectations relative to its price. In comparison to peers, Archit Organosys' PE ratio is substantially higher than that of Godrej Industries at 37.09, which is rated attractive, and Aarti Industries at 53.04, also rated fair. The company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -6.00% compared to the Sensex's 8.11%, further reinforcing the notion that Archit Organosys is currently overvalued.